Previous Article | Next Article 
Molecular and Cellular Biology, October 2003, p. 7230-7242, Vol. 23, No. 20
0270-7306/03/$08.00+0 DOI: 10.1128/MCB.23.20.7230-7242.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Myostatin Signals through a Transforming Growth Factor ß-Like Signaling Pathway To Block Adipogenesis
A. Rebbapragada,1 H. Benchabane,2,3 J. L. Wrana,2,3 A. J. Celeste,4 and L. Attisano1*
Department of Biochemistry,1
Department of Medical Genetics and Microbiology, University of Toronto, Toronto M5S 1A8,2
Program in Molecular Biology and Cancer, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto M5G 1X5, Canada,3
Wyeth Research, Cambridge, Massachusetts 021404
Received 21 October 2002/
Returned for modification 14 May 2003/
Accepted 14 July 2003
Myostatin, a transforming growth factor ß (TGF-ß) family member, is a potent negative regulator of skeletal muscle growth. In this study we characterized the myostatin signal transduction pathway and examined its effect on bone morphogenetic protein (BMP)-induced adipogenesis. While both BMP7 and BMP2 activated transcription from the BMP-responsive I-BRE-Lux reporter and induced adipogenic differentiation, myostatin inhibited BMP7- but not BMP2-mediated responses. To dissect the molecular mechanism of this antagonism, we characterized the myostatin signal transduction pathway. We showed that myostatin binds the type II Ser/Thr kinase receptor. ActRIIB, and then partners with a type I receptor, either activin receptor-like kinase 4 (ALK4 or ActRIB) or ALK5 (TßRI), to induce phosphorylation of Smad2/Smad3 and activate a TGF-ß-like signaling pathway. We demonstrated that myostatin prevents BMP7 but not BMP2 binding to its receptors and that BMP7-induced heteromeric receptor complex formation is blocked by competition for the common type II receptor, ActRIIB. Thus, our results reveal a strikingly specific antagonism of BMP7-mediated processes by myostatin and suggest that myostatin is an important regulator of adipogenesis.
* Corresponding author. Mailing address: Department of Biochemistry, Medical Sciences Bldg. Rm. 6336, University of Toronto, Toronto, ON M5S 1A8, Canada. Phone: (416) 946-3129. Fax: (416) 978-3954. E-mail: liliana.attisano{at}utoronto.ca.
Molecular and Cellular Biology, October 2003, p. 7230-7242, Vol. 23, No. 20
0022-538X/03/$08.00+0 DOI: 10.1128/MCB.23.20.7230-7242.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Li, X., McFarland, D. C., Velleman, S. G.
(2008). Effect of Smad3-Mediated Transforming Growth Factor-{beta}1 Signaling on Satellite Cell Proliferation and Differentiation in Chickens. Poult. Sci.
87: 1823-1833
[Abstract]
[Full Text]
-
Kondas, K., Szlama, G., Trexler, M., Patthy, L.
(2008). Both WFIKKN1 and WFIKKN2 Have High Affinity for Growth and Differentiation Factors 8 and 11. J. Biol. Chem.
283: 23677-23684
[Abstract]
[Full Text]
-
Rodgers, B. D., Garikipati, D. K.
(2008). Clinical, Agricultural, and Evolutionary Biology of Myostatin: A Comparative Review. Endocr. Rev.
29: 513-534
[Abstract]
[Full Text]
-
Li, Z. B., Kollias, H. D., Wagner, K. R.
(2008). Myostatin Directly Regulates Skeletal Muscle Fibrosis. J. Biol. Chem.
283: 19371-19378
[Abstract]
[Full Text]
-
Andersson, O., Korach-Andre, M., Reissmann, E., Ibanez, C. F., Bertolino, P.
(2008). Growth/differentiation factor 3 signals through ALK7 and regulates accumulation of adipose tissue and diet-induced obesity. Proc. Natl. Acad. Sci. USA
105: 7252-7256
[Abstract]
[Full Text]
-
Allen, D. L., Cleary, A. S., Speaker, K. J., Lindsay, S. F., Uyenishi, J., Reed, J. M., Madden, M. C., Mehan, R. S.
(2008). Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice. Am. J. Physiol. Endocrinol. Metab.
294: E918-E927
[Abstract]
[Full Text]
-
Guo, W., Flanagan, J., Jasuja, R., Kirkland, J., Jiang, L., Bhasin, S.
(2008). The Effects of Myostatin on Adipogenic Differentiation of Human Bone Marrow-derived Mesenchymal Stem Cells Are Mediated through Cross-communication between Smad3 and Wnt/{beta}-Catenin Signaling Pathways. J. Biol. Chem.
283: 9136-9145
[Abstract]
[Full Text]
-
Anderson, S. B., Goldberg, A. L., Whitman, M.
(2008). Identification of a Novel Pool of Extracellular Pro-myostatin in Skeletal Muscle. J. Biol. Chem.
283: 7027-7035
[Abstract]
[Full Text]
-
Kollias, H. D., McDermott, J. C.
(2008). Transforming growth factor-{beta} and myostatin signaling in skeletal muscle. J. Appl. Physiol.
104: 579-587
[Abstract]
[Full Text]
-
Nakatani, M., Takehara, Y., Sugino, H., Matsumoto, M., Hashimoto, O., Hasegawa, Y., Murakami, T., Uezumi, A., Takeda, S., Noji, S., Sunada, Y., Tsuchida, K.
(2008). Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice. FASEB J.
22: 477-487
[Abstract]
[Full Text]
-
Mendias, C. L., Bakhurin, K. I., Faulkner, J. A.
(2008). Tendons of myostatin-deficient mice are small, brittle, and hypocellular. Proc. Natl. Acad. Sci. USA
105: 388-393
[Abstract]
[Full Text]
-
Hirose, T., Nakazato, K., Song, H., Ishii, N.
(2008). TGF- 1 and TNF-{alpha} are involved in the transcription of type I collagen {alpha}2 gene in soleus muscle atrophied by mechanical unloading. J. Appl. Physiol.
104: 170-177
[Abstract]
[Full Text]
-
Kim, J.-s., Petrella, J. K., Cross, J. M., Bamman, M. M.
(2007). Load-mediated downregulation of myostatin mRNA is not sufficient to promote myofiber hypertrophy in humans: a cluster analysis. J. Appl. Physiol.
103: 1488-1495
[Abstract]
[Full Text]
-
Zhu, J., Li, Y., Shen, W., Qiao, C., Ambrosio, F., Lavasani, M., Nozaki, M., Branca, M. F., Huard, J.
(2007). Relationships between Transforming Growth Factor-beta1, Myostatin, and Decorin: IMPLICATIONS FOR SKELETAL MUSCLE FIBROSIS. J. Biol. Chem.
282: 25852-25863
[Abstract]
[Full Text]
-
Garikipati, D. K., Gahr, S. A., Roalson, E. H., Rodgers, B. D.
(2007). Characterization of Rainbow Trout Myostatin-2 Genes (rtMSTN-2a and -2b): Genomic Organization, Differential Expression, and Pseudogenization. Endocrinology
148: 2106-2115
[Abstract]
[Full Text]
-
Dragovic, R. A., Ritter, L. J., Schulz, S. J., Amato, F., Thompson, J. G., Armstrong, D. T., Gilchrist, R. B.
(2007). Oocyte-Secreted Factor Activation of SMAD 2/3 Signaling Enables Initiation of Mouse Cumulus Cell Expansion. Biol. Reprod.
76: 848-857
[Abstract]
[Full Text]
-
Yang, W., Zhang, Y., Li, Y., Wu, Z., Zhu, D.
(2007). Myostatin Induces Cyclin D1 Degradation to Cause Cell Cycle Arrest through a Phosphatidylinositol 3-Kinase/AKT/GSK-3beta Pathway and Is Antagonized by Insulin-like Growth Factor 1. J. Biol. Chem.
282: 3799-3808
[Abstract]
[Full Text]
-
Mukherjee, A., Sidis, Y., Mahan, A., Raher, M. J., Xia, Y., Rosen, E. D., Bloch, K. D., Thomas, M. K., Schneyer, A. L.
(2007). FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults. Proc. Natl. Acad. Sci. USA
104: 1348-1353
[Abstract]
[Full Text]
-
Allen, D. L., Unterman, T. G.
(2007). Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors. Am. J. Physiol. Cell Physiol.
292: C188-C199
[Abstract]
[Full Text]
-
Sim, F. J., Keyoung, H. M., Goldman, J. E., Kim, D. K., Jung, H.-W., Roy, N. S., Goldman, S. A.
(2006). Neurocytoma Is a Tumor of Adult Neuronal Progenitor Cells. J. Neurosci.
26: 12544-12555
[Abstract]
[Full Text]
-
Luo, J., Lin, A. H., Masliah, E., Wyss-Coray, T.
(2006). Bioluminescence imaging of Smad signaling in living mice shows correlation with excitotoxic neurodegeneration. Proc. Natl. Acad. Sci. USA
103: 18326-18331
[Abstract]
[Full Text]
-
Mendias, C. L., Marcin, J. E., Calerdon, D. R., Faulkner, J. A.
(2006). Contractile properties of EDL and soleus muscles of myostatin-deficient mice. J. Appl. Physiol.
101: 898-905
[Abstract]
[Full Text]
-
Kollias, H. D., Perry, R. L. S., Miyake, T., Aziz, A., McDermott, J. C.
(2006). Smad7 promotes and enhances skeletal muscle differentiation.. Mol. Cell. Biol.
26: 6248-6260
[Abstract]
[Full Text]
-
Mazerbourg, S., Hsueh, A. J.W.
(2006). Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands. Hum Reprod Update
12: 373-383
[Abstract]
[Full Text]
-
Yang, W., Chen, Y., Zhang, Y., Wang, X., Yang, N., Zhu, D.
(2006). Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinase Pathway Is Involved in Myostatin-Regulated Differentiation Repression. Cancer Res.
66: 1320-1326
[Abstract]
[Full Text]
-
Lee, S.-J., Reed, L. A., Davies, M. V., Girgenrath, S., Goad, M. E. P., Tomkinson, K. N., Wright, J. F., Barker, C., Ehrmantraut, G., Holmstrom, J., Trowell, B., Gertz, B., Jiang, M.-S., Sebald, S. M., Matzuk, M., Li, E., Liang, L.-f., Quattlebaum, E., Stotish, R. L., Wolfman, N. M.
(2005). Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proc. Natl. Acad. Sci. USA
102: 18117-18122
[Abstract]
[Full Text]
-
Muenster, U., Harrison, C. A., Donaldson, C., Vale, W., Fischer, W. H.
(2005). An Activin-A/C Chimera Exhibits Activin and Myostatin Antagonistic Properties. J. Biol. Chem.
280: 36626-36632
[Abstract]
[Full Text]
-
Mazerbourg, S., Sangkuhl, K., Luo, C.-W., Sudo, S., Klein, C., Hsueh, A. J. W.
(2005). Identification of Receptors and Signaling Pathways for Orphan Bone Morphogenetic Protein/Growth Differentiation Factor Ligands Based on Genomic Analyses. J. Biol. Chem.
280: 32122-32132
[Abstract]
[Full Text]
-
Artaza, J. N., Bhasin, S., Magee, T. R., Reisz-Porszasz, S., Shen, R., Groome, N. P., Fareez, M. M., Gonzalez-Cadavid, N. F.
(2005). Myostatin Inhibits Myogenesis and Promotes Adipogenesis in C3H 10T(1/2) Mesenchymal Multipotent Cells. Endocrinology
146: 3547-3557
[Abstract]
[Full Text]
-
Lin, A. H., Luo, J., Mondshein, L. H., ten Dijke, P., Vivien, D., Contag, C. H., Wyss-Coray, T.
(2005). Global Analysis of Smad2/3-Dependent TGF-{beta} Signaling in Living Mice Reveals Prominent Tissue-Specific Responses to Injury. J. Immunol.
175: 547-554
[Abstract]
[Full Text]
-
Samad, T. A., Rebbapragada, A., Bell, E., Zhang, Y., Sidis, Y., Jeong, S.-J., Campagna, J. A., Perusini, S., Fabrizio, D. A., Schneyer, A. L., Lin, H. Y., Brivanlou, A. H., Attisano, L., Woolf, C. J.
(2005). DRAGON, a Bone Morphogenetic Protein Co-receptor. J. Biol. Chem.
280: 14122-14129
[Abstract]
[Full Text]
-
Kaivo-Oja, N., Mottershead, D. G., Mazerbourg, S., Myllymaa, S., Duprat, S., Gilchrist, R. B., Groome, N. P., Hsueh, A. J., Ritvos, O.
(2005). Adenoviral Gene Transfer Allows Smad-Responsive Gene Promoter Analyses and Delineation of Type I Receptor Usage of Transforming Growth Factor-{beta} Family Ligands in Cultured Human Granulosa Luteal Cells. J. Clin. Endocrinol. Metab.
90: 271-278
[Abstract]
[Full Text]
-
del Re, E., Sidis, Y., Fabrizio, D. A., Lin, H. Y., Schneyer, A.
(2004). Reconstitution and Analysis of Soluble Inhibin and Activin Receptor Complexes in a Cell-free System. J. Biol. Chem.
279: 53126-53135
[Abstract]
[Full Text]
-
Rios, R., Fernandez-Nocelos, S., Carneiro, I., Arce, V. M., Devesa, J.
(2004). Differential Response to Exogenous and Endogenous Myostatin in Myoblasts Suggests that Myostatin Acts as an Autocrine Factor in Vivo. Endocrinology
145: 2795-2803
[Abstract]
[Full Text]
-
Mazerbourg, S., Klein, C., Roh, J., Kaivo-Oja, N., Mottershead, D. G., Korchynskyi, O., Ritvos, O., Hsueh, A. J. W.
(2004). Growth Differentiation Factor-9 Signaling Is Mediated by the Type I Receptor, Activin Receptor-Like Kinase 5. Mol. Endocrinol.
18: 653-665
[Abstract]
[Full Text]
Copyright © 2003 by the American Society for Microbiology. All rights reserved.